SXSW 2024

FDA Approved Love? Exploring MDMA's Psychedelic Journey


We're witnessing history in the making as MDMA is expected to be the first psychedelic approved by the FDA, potentially transforming how we treat mental health. This is a unique opportunity to hear from key figures deeply intertwined with MDMA's unlikely path from the dance floor to late-stage clinical trials to... potentially the therapist's couch. We’ll take a captivating journey to explore just how this former party is making its way into so many of our lives as a uniquely therapeutic medicine. Featuring Rick Doblin, Julie Holland, Rachel Nuwer, and Daniel Goldberg

Related Media

Other Resources / Information


  1. Exploring the history and future of MDMA; hear from "OG's" who have been advocating for MDMA long for decades under prohibition...
  2. Understand why and how MDMA is leading the psychedelic medicalization movement
  3. Separating fact from fantasy, and hope from hype about this unique molecule



Daniel Goldberg, Co-Founder, Palo Santo Fund

Meta Information:

  • Event: SXSW
  • Format: Panel
  • Track: Psychedelics
  • Track 2
  • Level: Beginner

Add Comments

comments powered by Disqus

SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.